Open access
59
Views
1
CrossRef citations to date
0
Altmetric
Original Research
Health care resource utilization before and after natalizumab initiation among patients with multiple sclerosis in Germany
Crystal Watson1 Health Economics and Outcomes Research, Global Market Access, Biogen, Cambridge, MA, USACorrespondence[email protected]
, Christine Prosser2 Real World Evidence, Xcenda GmbH, Hanover, Germany
, Sebastian Braun2 Real World Evidence, Xcenda GmbH, Hanover, Germany
, Pamela B Landsman-Blumberg3 Applied Data Analytics, Xcenda LLC, Palm Harbor, FL, USA
, Erika Gleissner4 Market Access, Biogen, Ismaning, Germany
& Sarah Naoshy1 Health Economics and Outcomes Research, Global Market Access, Biogen, Cambridge, MA, USA
Pages 85-97
|
Published online: 01 Feb 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.